At this year’s BIO International Convention, Managing Partner Michael Abrams led the panel, How EU Reimbursement Hurdles Will Become the Norm in the U.S., with panelists Stefan Seliger, Head of Pricing and Reimbursement at Roche Pharmaceuticals, Alexander Natz, Secretary General of the European Confederation of Pharmaceutical Entrepreneurs, and Laura Spiegel, Group Marketing Manager, Strategy and Innovation at Roche Diagnostics.  These experts shared lessons learned from dealing with European reimbursement agencies, and discussed how some of these measures might be implemented in the U.S. market.